Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Jun 04, 2009 2:51am
122 Views
Post# 16042394

Zactima and 4601

Zactima and 4601
Last night I wrote about Astra Pipeline and how 4601 would fit with it.
https://www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27188588&l=0&r=0&s=TLN&t=LIST


Astra is now adopting a collaboration approach for it's pipeline and personalized medecine strategy to salvage as much value as possible.


Astra has been heavily investing in Zactima & Recentin, which could turn out okay but not great or worse they could become big money losers.

Zactima is the least impressive PIII compound available. A TKI inhibitor which was believe to be superior to (tarceva and avastin combo).

However it failed twice https://online.wsj.com/article/BT-CO-20090530-701181.html and is still unconvincing.

Combo with 4601 would salvage that drug.


Acquistion of 4601 would fit AstraZeneca pipeline, also gives it new hope and fits perfectly with their strategy.
Bullboard Posts